Stock Analysis on Net

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

$24.99

Statement of Comprehensive Income

Paying users area

The data is hidden behind: . Unhide it.

  • Get 1-month access to Vertex Pharmaceuticals Inc. for $24.99, or

  • get full access to the entire website for at least 3 months from $62.19.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Vertex Pharmaceuticals Inc., consolidated statement of comprehensive income

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income
Unrealized holding gains (losses) on marketable securities, net of tax
Unrealized gains (losses) on foreign currency forward contracts, net of tax
Foreign currency translation adjustment
Other comprehensive income (loss)
Comprehensive income

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Comprehensive income item Description The company
Net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Vertex Pharmaceuticals Inc. net income increased from 2021 to 2022 and from 2022 to 2023.
Comprehensive income Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Vertex Pharmaceuticals Inc. comprehensive income increased from 2021 to 2022 and from 2022 to 2023.